Disturbed secretory capacity for macrophage inflammatory protein (MIP)-1α and MIP-1β in progressive HIV infection

AIDS Research and Human Retroviruses

Volumn 20, Issue 10, 2004, Pages 1087-1091

  Jennes, Wim ^a   Vereecken, Chris ^a   Fransen, Katrien ^a   De Roo, Ann ^a   Kestens, Luc ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; CELL CULTURE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELLS, CULTURED; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES; T-LYMPHOCYTES;

EID: 6344275434     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1087     Document Type: Article

References (17)

1. Cocchi F, DeVico AL, Garano-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α, and MIP-β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
2. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-534.
3. Ullum H, Cozzi LA, Victor J, et al.: Production of β-chemokines in human immunodeficiency virus (HIV) infection: Evidence that high levels of macrophage inflammatory protein-1β are associated with a decreased risk of HIV disease progression. J Infect Dis 1998;177:331-336.
4. Cocchi F, DeVico AL, Yarchoan R, et al.: Higher macrophage inflammatory protein (MIP)-1α and MIP-β levels from CD8+ T cells are associated with asymptomatic HIV-I infection. Proc Natl Acad Sci USA 2000;97:13812-13817.
5. Tartakovsky B, Burke M, Vardinon N, et al.: Increased intracellular macrophage inflammatory protein-1β correlates with advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:1-5.
6. Tartakovsky B, Turner D, Vardinon N, Burke M, and Yust I: Increased intracellular accumulation of macrophage inflammatory protein 1β and its decreased secretion correlates with advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:420-422.
7. Jennes W, Sawadogo S, Koblavi-Deme S, et al.: Positive association between β-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Cote d'Ivoire. AIDS Res Hum Retroviruses 2002;18:171-177.
8. Sousa AE, Chaves AF, Doroana M, Antunes F, and Victorino RM: Bulk cytokine production versus frequency of cytokine-producing cells in HIV-1 infection before and during HAART. Clin Immunol 2000;97:162-170.
9. Ahmad R, Sindhu ST, Toma E, Morisset R, and Ahmad A: Studies on the production of IL-15 in HIV-infected/AIDS patients. J Clin Immunol 2003;23:1-90.
10. Portales P, Reynes J, Pinet V, et al.: Interferon-α restores HIV-induced alteration of natural killer cell perforin expression in vivo. AIDS 2003;17:495-504.
11. Migueles SA, Laborico AC, Shupert WL, et al.: HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002;3:1061-1068.
12. Zhang D, Shankar P, Xu Z, et al.: Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 2003;101:226-235.
13. Castelli JC, Deeks SG, Shiboski S, and Levy JA: Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood 2002;99:4225-4227.
14. Catalfamo M, Karpova T, McNally J, et al.: Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 2004;20:219-230.
15. Kumar D, Parato K, Kumar A, Sun E, Cameron DW, and Angel JB: Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1α and MIP-1β. AIDS Res Hum Retroviruses 1999;15:1073-1077.
16. Carter LM, Peters BS, Ellis BA, and Wolstencroft RA: Highly active antiretroviral therapy normalizes the potential for MIP-1α production in HIV infection. J Infect 2000;41:252-255.
17. Clerici M, Seminari E, Maggiolo F, et al.: Early and late effects of highly active antiretroviral therapy: A 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients. AIDS 2002;16:1767-1773.